These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 156337

  • 41. Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen.
    Fukuda M, Yamaguchi S, Ohta T, Nakayama Y, Ogata H, Shimizu K, Nishikawa T, Adachi Y, Fukuma E.
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):77-81. PubMed ID: 10442369
    [Abstract] [Full Text] [Related]

  • 42. Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
    Muggia FM, Perloff M, Chia GA, Reed LJ, Escher GC.
    Cancer Chemother Rep; 1974 Jul; 58(6):919-26. PubMed ID: 4614899
    [No Abstract] [Full Text] [Related]

  • 43. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT, Palshof T.
    Prog Clin Biol Res; 1977 Jul; 12():459-66. PubMed ID: 335404
    [No Abstract] [Full Text] [Related]

  • 44. Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer.
    Lloyd RE, Jones SE, Salmon SE.
    Cancer; 1979 Jan; 43(1):60-5. PubMed ID: 153787
    [Abstract] [Full Text] [Related]

  • 45. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE, Machiavelli M, Romero A, Leone BA, Rabinovich MG, Arévalo E.
    Medicina (B Aires); 1982 Jan; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract] [Full Text] [Related]

  • 46. Chemotherapy of breast cancer.
    Mitchell MS.
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract] [Full Text] [Related]

  • 47. [Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)].
    Fiebig HH, Schmähl D.
    Klin Wochenschr; 1977 May 01; 55(9):445-50. PubMed ID: 406478
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.
    Priestman T, Baum M, Jones V, Forbes J.
    Br Med J; 1977 May 14; 1(6071):1248-50. PubMed ID: 324570
    [Abstract] [Full Text] [Related]

  • 51. [Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].
    Matthiessen W, Pochhammer KF.
    Prax Pneumol; 1976 Aug 14; 30(8):479-8. PubMed ID: 959156
    [No Abstract] [Full Text] [Related]

  • 52. Letter: Adriamycin in advanced breast cancer.
    Hoeffken K, Boecker WR, Schmidt CG.
    Lancet; 1976 Feb 14; 1(7955):360. PubMed ID: 54763
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M, Goldhirsch A.
    Onkologie; 2003 Apr 14; 26(2):111-2. PubMed ID: 12771517
    [No Abstract] [Full Text] [Related]

  • 55. [Combination of adriamycin and cyclophosphamide (alone or with other substances) in the treatment of breast cancer].
    Salmon SE, Jones SE.
    Onkologie; 1979 Apr 14; 2(2):45-52. PubMed ID: 93257
    [Abstract] [Full Text] [Related]

  • 56. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
    Irwin LE, Chlebowski RT, Weiner JM, Reynolds R, Pugh RP, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1980 Apr 14; 64(8-9):981-4. PubMed ID: 7004635
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
    Greenspan EM.
    Mt Sinai J Med; 1972 Apr 14; 39(5):435-46. PubMed ID: 4628078
    [No Abstract] [Full Text] [Related]

  • 59. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
    Klefström P.
    Cancer Treat Rep; 1980 Jan 14; 64(1):65-72. PubMed ID: 6991105
    [Abstract] [Full Text] [Related]

  • 60. Evaluation of quality of life in patients receiving treatment for advanced breast cancer.
    Priestman TJ, Baum M.
    Lancet; 1976 Apr 24; 1(7965):899-900. PubMed ID: 58161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.